David G. Telander MD PhD

Retinal Disease

Retinal Consultants of Sacramento; Clinical Professor at UC Davis

3939 J StSte 106Sacramento, CA 95819
Phone+1 916-454-4861
Fax+1 916-454-3603

Dr. Telander is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Telander's full profile Already have an account?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Surgical Retina and Vitreous, 2003 - 2005
University of MinnesotaResidency, Ophthalmology, 2000 - 2003
Hennepin HealthcareInternship, Transitional Year, 1999 - 2000
Stanford UniversityBAS, Biology and History, 1986 - 2000
University of Minnesota Medical SchoolClass of 1999

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2003 - 2026
MN State Medical License 1999 - 2003
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011, 2015-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2015-2017
CMS Meaningful Use Stage 2 Certification HouseCalls, TeleVox Software, 2011, 2015-2017

Clinical Trials

Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD)
COMPLETED
PHASE2
Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration Start of enrollment: 2015 Apr 01
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2

Publications & Presentations

PubMed

16 citations
METformin for the MINimization of Geographic Atrophy Progression (METforMIN): A Randomized Trial.
Liangbo Linus Shen, Jeremy D Keenan, Noor Chahal, Abu Tahir Taha, Jasmeet Saroya
Ophthalmology Science. 2023-12-04
7 citations
Myo/Nog cells expressing muscle proteins are present in preretinal membranes from patients with proliferative vitreoretinopathy
Jacquelyn Gerhart, Nathan Morrison, Lindsay Gugerty, David G. Telander, Arturo Bravo-Nuevo
Experimental Eye Research. 2020-05-29
4 citations
Comparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone Acetonide
Zeljka Smit-McBride, Elad Moisseiev, Sara P. Modjtahedi, David G. Telander, Leonard M. Hjelmeland
Journal of Ophthalmology. 2016-06-27

Press Mentions

Clinical Trial in Dry-AMD with the Opening of Two Additional U.S. SitesMay 24th, 2018
Dr. David Telander Named Among the Top 1% of Doctors in the NationMarch 10th, 2016